Drug
luspatercept
Marketed as REBLOZYL.
Generic name
luspatercept
Brand names
REBLOZYL
First FDA approval
2019-11-08
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761136 | REBLOZYL | 2019-11-08 | CELGENE CORP |
Manufacturers
CELGENE CORP
Frequently asked questions
When was luspatercept FDA approved?
Earliest FDA approval on record: 2019-11-08.
What brand names are sold as luspatercept?
REBLOZYL.
Sources
Appeal a luspatercept denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com